News & Events

8th International Congress on Cancer Metastasis

8th International Congress on Cancer Metastasis

The 8th iteration of the Congress brings together international experts in oncology, immunobiology, pharmacology, molecular biology and molecular imaging to discuss preclinical, translational and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine. With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than thought imaginable. We hope you will participate in 8th International Congress on Cancer Metastasis, scheduled for October 25-27, 2019 in San Francisco, California.

The Symposium is sponsored by the Sentinel Node Oncology Foundation, a 501(c)(3) non-profit organization founded in 2003 to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments. The Organizing Committee is building a program that follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment and survival. The theme of the Symposium is to track the single cell in our body, that has become a mutant cell, which proliferates with resultant mutants being selected to become the fittest clone to spread through the lymphovascular system using the sentinel lymph node as the primary gateway to distant sites to cause devastation to the body. It is a journey that we have to understand from a molecular level so that it can be stopped before the mutants go awry.

October 25-27, 2019 San Francisco, USA Preceding the ACS Clinical Congress 2019
Physician(s) over 150 attending medical physicians Thursday-Sunday.

PT, OT and Speech Therapist, patients, physicians SATURDAY October 26:  CEU lymphedema conference

For more information, click here.